SCICLONE PHARMACEUTICALS INC: accounts_receivable
| Value | {"amount": 40200000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-03-31) |
| Status | current |
| Entity | SCICLONE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/15c9175d-77da-4b08-bca1-b121990893f9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-136851Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000880771/accounts-receivable/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/15c9175d-77da-4b08-bca1-b121990893f9
History
- supersedes {"amount": 42056000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0001193125-12-225450)